Causes of Apical Cap Aneurysm in Hypertrophic Cardiomyopathy
Apical cap aneurysm in hypertrophic cardiomyopathy is primarily caused by myocardial ischemia and infarction resulting from microvascular dysfunction, even in the absence of epicardial coronary artery disease. 1
Primary Pathophysiologic Mechanisms
1. Myocardial Ischemia
Oxygen Supply-Demand Mismatch
Exacerbating Factors
2. Structural and Hemodynamic Contributors
Regional Wall Stress
Progressive Remodeling
Diagnostic Features and Identification
Imaging Characteristics
- Defined as a discrete thin-walled dyskinetic or akinetic segment of the most distal portion of the LV chamber 1
- Often associated with transmural scar or late gadolinium enhancement (LGE) on CMR imaging 1
- Independent of size, but represents a distinct morphological abnormality 1
Detection Methods
- CMR imaging is particularly valuable for detection of apical aneurysms that may be missed by echocardiography 1
- Late gadolinium enhancement on CMR helps identify associated myocardial fibrosis and scarring 1
Clinical Significance
Risk Implications
Apical aneurysms are associated with increased risk of:
- Sudden cardiac death
- Heart failure progression
- Ventricular arrhythmias
- Thromboembolic events including stroke 1
Considered an independent risk factor for adverse outcomes in HCM 1
Prevalence
- Occurs in approximately 2% of patients with HCM 1
- May be underrecognized without appropriate imaging techniques 1
Distinguishing Features from Other Aneurysm Types
Unlike post-myocardial infarction aneurysms that result from epicardial coronary artery occlusion, apical aneurysms in HCM develop despite normal coronary arteries due to microvascular dysfunction and regional ischemia 2.
Clinical Management Implications
The presence of an apical aneurysm should prompt consideration of:
- Anticoagulation to prevent thromboembolic events 4
- ICD implantation for primary prevention of sudden cardiac death 1
- Potential catheter ablation for associated ventricular arrhythmias 4, 3
Understanding the pathophysiology of apical aneurysm formation is crucial for risk stratification and management decisions in patients with HCM.